Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 133.00M | $ 228.00M | $ 113.20M | $ 113.60M | $ 146.80M |
Total Assets | $ 981.30M | $ 859.10M | $ 709.60M | $ 652.80M | $ 750.80M |
Total Debt | $ 435.70M | $ 393.80M | $ 384.10M | $ 366.40M | $ 174.70M |
Net Debt | $ 302.70M | $ 165.80M | $ 270.90M | $ 252.80M | $ 27.90M |
Total Liabilities | $ 634.80M | $ 530.90M | $ 506.00M | $ 502.10M | $ 650.40M |
Stockholders Equity | $ 346.50M | $ 328.20M | $ 203.60M | $ 150.70M | $ 100.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |